What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His primary areas of investigation include Internal medicine, Gastroenterology, Immunology, Pathology and Liver biopsy.
His work in Internal medicine is not limited to one particular discipline; it also encompasses Surgery.
The Gastroenterology study combines topics in areas such as Nonalcoholic fatty liver disease and Steatohepatitis.
His Immunology research is multidisciplinary, relying on both Mutation and Cytotoxic T cell.
His work on Biopsy as part of general Pathology research is frequently linked to Consensus development, thereby connecting diverse disciplines of science.
His study in Steatosis is interdisciplinary in nature, drawing from both TM6SF2, Adiponutrin and Insulin resistance.
His most cited work include:
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease (6077 citations)
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis (1964 citations)
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (1266 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Pathology, Immunology and Liver biopsy.
Nonalcoholic fatty liver disease, Cirrhosis, Fibrosis, Liver disease and Fatty liver are among the areas of Internal medicine where the researcher is concentrating his efforts.
David E. Kleiner focuses mostly in the field of Cirrhosis, narrowing it down to topics relating to Hepatitis B and, in certain cases, Hepatitis B virus.
His Gastroenterology research incorporates themes from Biopsy, Steatohepatitis, Liver injury and Hepatitis C.
His Pathology research includes themes of Hepatocellular carcinoma, Cancer research, Nodular regenerative hyperplasia and Hepatitis.
The concepts of his Liver biopsy study are interwoven with issues in Autoimmune hepatitis and Hepatology.
He most often published in these fields:
- Internal medicine (52.20%)
- Gastroenterology (37.00%)
- Pathology (27.11%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (52.20%)
- Gastroenterology (37.00%)
- Fibrosis (11.17%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Gastroenterology, Fibrosis, Nonalcoholic fatty liver disease and Cirrhosis.
His work in Liver biopsy, Steatosis, Liver disease, Biopsy and Steatohepatitis are all subfields of Internal medicine research.
Steatohepatitis is a primary field of his research addressed under Fatty liver.
David E. Kleiner studies Gastroenterology, focusing on Transient elastography in particular.
His Fibrosis study which covers Hepatology that intersects with Hepatitis.
His research integrates issues of Stage, Endocrinology, Metabolic syndrome and Chronic liver disease in his study of Nonalcoholic fatty liver disease.
Between 2018 and 2021, his most popular works were:
- Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. (140 citations)
- 17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease (103 citations)
- Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease. (98 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
David E. Kleiner spends much of his time researching Internal medicine, Gastroenterology, Steatosis, Nonalcoholic fatty liver disease and Fibrosis.
His study in Internal medicine focuses on Steatohepatitis, Cirrhosis, Fatty liver, Liver injury and Liver disease.
His Fatty liver study incorporates themes from Clinical endpoint, Randomized controlled trial, Intention-to-treat analysis and Comorbidity.
In his study, which falls under the umbrella issue of Liver disease, Lung is strongly linked to Variceal bleeding.
The various areas that David E. Kleiner examines in his Gastroenterology study include Interquartile range, Biopsy, Liver biopsy, Confidence interval and Prospective cohort study.
His Fibrosis study integrates concerns from other disciplines, such as Clinical trial, Disease and MEDLINE.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
